Thin Film Drug Manufacturing Market Expected to Grow at 8.9% CAGR Through 2030: Industry Forecast
The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.
How Does the Market Size of the Thin Film Drug Manufacturing Market in 2030 Compare With That of 2026?
The thin film drug manufacturing market size has grown strongly in recent years. It will grow from $8.71 billion in 2025 to $9.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to difficulty in swallowing conventional tablets, growing focus on patient compliance, early adoption of oral dissolving technologies, rising demand for rapid onset therapies, expansion of hospital pharmacy distribution.
The thin film drug manufacturing market size is expected to see strong growth in the next few years. It will grow to $13.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to advancements in thin film formulation technologies, growing prevalence of neurological disorders, expansion of e-commerce pharmaceutical distribution, increasing investment in novel drug delivery systems, rising regulatory approvals for thin film drugs. Major trends in the forecast period include rising adoption of oral thin films for rapid drug delivery, increasing demand for patient-friendly dosage forms, growth in use of thin films for neurological and cns disorders, expansion of taste-masked and orodispersible film technologies, rising application of thin films in migraine and opioid dependence treatment.
Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/thin-film-drug-manufacturing-global-market-report
Which Drivers Are Positively Impacting the Thin Film Drug Manufacturing Market?
The increase in the global elderly population is expected to propel the growth of the thin-film drug manufacturing market going forward. The rise in the global elderly population is influenced by extended life expectancies, medical advancements, improved nutrition and healthcare, and changes in family structures and societal norms. Thin film drug manufacturing helps meet the needs of the growing elderly population by offering improved medication adherence, ease of use, precise dosage control, rapid dissolution, and enhanced stability, which together supports better management of chronic conditions and overall health in older adults. For instance, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. Therefore, the increase in the global elderly population is driving the thin film drug manufacturing market.
What Segment Categories Define the Thin Film Drug Manufacturing Market Structure?
The thin film drug manufacturing market covered in this report is segmented –
1) By Type: Oral Thin Film, Transdermal Film, Other Types
2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea And Vomiting, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-Commerce
Subsegments:
1) By Oral Thin Film: SubLingual Films, Buccal Films, Orodispersible Films, Taste-Masked Oral Films
2) By Transdermal Film: Adhesive Transdermal Films, Matrix Transdermal Films, Reservoir Transdermal Films, Drug-Eluting Transdermal Films
3) By Other Types: Topical Films, Ophthalmic Films, Intranasal Films, Veterinary Thin Films
What Are the Key Industry Trends Transforming the Thin Film Drug Manufacturing Market?
Major companies operating in the thin film drug manufacturing market are focusing on developing innovative products, such as oral thin film technologies, to enhance patient compliance and ease of use. Oral thin film technologies involve creating rapidly dissolving films that deliver medication through the mucous membranes in the mouth for quick absorption. These films offer a convenient, effective, and user-friendly alternative to traditional oral dosage forms such as tablets and capsules. For instance, in April 2023, IntelGenx Corporation, a Canada-based pharmaceutical company, announced the Food and Drug Administration (FDA) approval of RIZAFILM for the treatment of acute migraine. This new formulation allows for rapid dissolution and absorption, potentially providing faster relief for migraines compared to traditional tablets. This innovation enhances bioavailability and offers a more convenient, user-friendly option, improving patient compliance. The thin film technology enhances patient compliance and ease of use, making it a more user-friendly alternative for managing acute migraine attacks.
Who Are the Most Influential Players in the Thin Film Drug Manufacturing Market?
Major companies operating in the thin film drug manufacturing market are Novartis AG, Merck KGaA, Dr. Reddy's Laboratories, Indivior PLC, LTS Lohmann Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark, AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.
Get the full thin film drug manufacturing market report here:
https://www.thebusinessresearchcompany.com/report/thin-film-drug-manufacturing-global-market-report
How does the Thin Film Drug Manufacturing Market perform across different regions?
North America was the largest region in the thin film drug manufacturing market in 2025. The regions covered in the thin film drug manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment